Now Reading
Weill Cornell Medicine

Weill Cornell Medicine

Weill Cornell Medicine is the biomedical research unit and medical school of Cornell University, a private Ivy League university

Reversing osteoporosis . . . in mice

A molecule promoting blood vessel growth in bone can create an environment suitable for bone-building formation, representing a potential target for new drugs to treat osteoporosis and fractures, according to new research by Weill Cornell Medicine scientists. The findings, published May 21 in Nature Medicine, show that a substance, which is best known for spurring nerve

Reversing osteoporosis . . . in mice

A nanotechnology-enhanced biochip could detect cancers, malaria and viral diseases in their progression with a pin prick blood test

The difficulty in spotting minute amounts of disease circulating in the bloodstream has proven a stumbling block in the detection and treatment of cancers that advance stealthily with few symptoms. With a novel electrochemical biosensing device that identifies the tiniest signals these biomarkers emit, a pair of NJIT inventors are hoping to bridge this gap.

A nanotechnology-enhanced biochip could detect cancers, malaria and viral diseases in their progression with a pin prick blood test

Artificial intelligence weighs in on whether an in vitro fertilized human embryo has a high potential to progress to a successful pregnancy

A new artificial intelligence approach by Weill Cornell Medicine investigators can identify with a great degree of accuracy whether a 5-day-old, in vitro fertilized human embryo has a high potential to progress to a successful pregnancy. The technique, which analyzes time-lapse images of the early-stage embryos, could improve the success rate of in vitro fertilization

Artificial intelligence weighs in on whether an in vitro fertilized human embryo has a high potential to progress to a successful pregnancy

Toxin-Emitting Bacteria Being Evaluated as a Potential Multiple Sclerosis Trigger

VARIANT OF COMMON SOIL-BASED PATHOGEN FOUND FOR THE FIRST TIME IN A PATIENT WITH MS RESEARCHERS FIND EVIDENCE OF SIMILAR INFECTION IN OTHER MS PATIENTS A research team from Weill Cornell Medical College and The Rockefeller University has identified a bacterium it believes may trigger multiple sclerosis (MS), a chronic, debilitating disorder that damages myelin

Toxin-Emitting Bacteria Being Evaluated as a Potential Multiple Sclerosis Trigger

The Latest Bing News on:
Weill Cornell Medicine Research
The Latest Bing News on:
Weill Cornell Medicine Discovery
What's Your Reaction?
Don't Like it!
0
I Like it!
0
View Comments (0)

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Scroll To Top